New blood test may help detect breast cancer
Another study published by the Clinical Breast Cancer has proven the usefulness of Videssa Breast as a diagnostic complement to images of women with abnormal findings and has shown that it could potentially reduce biopsy use by as much as 67%. "The use of biomarkers for cancer detection is a major advance in the management of women with dense breasts and in navigating many diagnostic challenges. As a clinician, the ability to identify who will benefit most, monitor and rule out breast cancer in women, when they get suspected findings, is tremendous, "says Elayne Arterbery, a St. Mary's of Saginaw oncologist." This study also validates the scientific promise and increasing role of biomarkers in addressing diagnostic challenges for women with breasts dense and the merits of new research to help expand the way we put that science to benefit women, "she concludes.
With few exceptions, going to the doctor does not set up leisure activity. The visit has a purpose that probably involves the preservation and / or restoration of your well-being and autonomy. In this light, you should think of the doctor as an instrument for a task. If you choose the right instrument, the task makes it easier, if not, you are buying a problem.
Treatments against prostate cancer that regulate the male hormone testosterone are currently associated with a higher risk of heart attack. But a new analysis by researchers at Boston's Dana-Farber / Brigham and Women's Cancer Center ( ) indicates that this risk may be minimal for most men. Over the past year, health groups, such as the American Heart Association, the American Cancer Society, and the American Urological Association, issued a statement to alert physicians and patients about the risks of such treatment.